Expedite your therapeutics discovery and development programs with confidence using ready-to-use assay kits, stable cell lines, membrane preps, proteins/enzymes, and qualified reagents from Eurofins DiscoverX, the trusted product solutions provider.
Customer Service and Technical Support. Obtain information about contacting us, our partners, or distributors for your inquiries, and review frequently asked questions (FAQs) about ordering and technical or scientific issues. Contact Us.
Distributors. We are interested in committed and well established distributors helping us to commercialize our products into their own drug discovery research and screening markets. Please contact us if you are interested in distributing our product range.
Latest News & Insights. Stay current on our latest innovations, products, and science news in our weekly Drug Discovery and Development Email Newsletter. Subscribe today and tap into our most recent products and assets. PRODUCTS. Products. Applications. Target Classes. Drug Discovery & Developement.
Drug discovery programs for developing therapeutics targeting GPCRs go through several steps, from the identification and characterization of the GPCR through pre-clinical testing (see Figure 2. for a detailed breakdown of these steps).
These cookies are necessary for the website to function and cannot be switched off in our systems. They are usually only set in response to actions made by you which amount to a request for services, such as setting your privacy preferences, logging in or filling in forms.
Drug Discovery & Development Phase- Appropriate Solutions | Our Expertise in Your Hands – Discover Confidently Additional SPRINTer Cell Lines for Target Protein Degradation
9 X A 157.3 Nine different assays were performed on different days, by two analysts and in two separate buildings. The analysts tested samples from 50% to 150% relative potency compared to the reference sample (100%). Measured relative potencies are indicated on the table above. The assay has a maximum inaccuracy within 13% for the 50% sample ...